Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mark Schiefermeier"'
Autor:
Mark Schiefermeier, Ephraim Yavin
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 1, Pp 124-131 (2002)
The last period of the intrauterine life in the rat (embryonic day 17 to 21, ED17–ED21) is demarcated by an increase in brain and body weight and active neuronogenesis. During this period, a rapid accumulation of DHA (22:6 n-3), unparalleled to oth
Externí odkaz:
https://doaj.org/article/6816fef22cf046eebdef31f53cd36630
Autor:
Menci Kunstelj, Simon Caserman, Simona Jevsevar, Tanja Milunović, Mateja Kusterle, Vladka Gaberc Porekar, Mark Schiefermeier
Publikováno v:
Analytical Biochemistry. 389:27-31
Pegylation is the most widely used and accepted methodology for half-life extension of biopharmaceutical drugs that also improves physicochemical and biological characteristics of proteins considerably. Most of the positive pharmacological effects of
Autor:
Bruno Schneeweiss, Christian Zauner, Martin G. Bischof, Mark Schiefermeier, K. Ratheiser, Christian Anderwald, Petra Nimmerrichter, Alexandra Zauner
Publikováno v:
Metabolism. 56:1-5
Critical illness is characterized by a hypermetabolic state associated with increased mortality, which is partly ascribed to the occurrence of hyperglycemia caused by enhanced endogenous glucose production and insulin resistance (IR). Insulin resista
Autor:
K. Ratheiser, Petra Nimmerrichter, Alexandra Zauner, Mark Schiefermeier, Ulrike Holzinger, Christian Zauner
Publikováno v:
Wiener klinische Wochenschrift. 116:603-607
OBJECTIVE: Hyperglycemia and protein catabolism frequently occur in critically ill patients and both are associated with increased complication rates. These metabolic alterations can be improved by insulin administered exogenously. Since a wide range
Autor:
Hildegard Greinix, Bruno Schneeweiss, Klaus Ratheiser, Christian Zauner, Peter Kalhs, Mark Schiefermeier, Werner Rabitsch, Felix Keil
Publikováno v:
Transplantation. 71:524-528
Background. Allogeneic stem cell transplantation is frequently complicated by graft-versus-host disease (GVHD). Weight loss is one of the characteristic features of GVHD. The etiology of weight loss in GVHD is not completely understood. Methods. We m
Autor:
Andreas Premstaller, Werner Brunner, Thomas Stangler, Michael Melmer, Alfred Rupprechter, Hansjörg Toll, Mark Schiefermeier, Wolfgang Lindner
Publikováno v:
Analytical and bioanalytical chemistry. 398(2)
In contrast with conventional drugs, biopharmaceuticals are highly complex molecules with remarkable heterogeneity. Protein glycosylation is an inherent source of this heterogeneity and also affects the safety, efficacy, and serum half-life of therap
Autor:
Alfred Gangl, Mark Schiefermeier, Michael Fangl, Klaus Ratheiser, A. Kranz, Christian Zauner, Veronika Birner, Ludwig Kramer
Publikováno v:
Critical Care Medicine. 26:125A
Autor:
Fritz Sterz, Georg Funk, Elisabeth Oschatz, Philip Eisenburger, Julia Kofler, Christian Madl, Lueder Deecke, Mark Schiefermeier, Harald Kollegger, Michael Holzer, Claudia Schwarz, Fritz Zimprich
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d670787b6e9753d461f4b43d53e9ae9
http://www.scopus.com/inward/record.url?eid=2-s2.0-33750644241&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-33750644241&partnerID=MN8TOARS